UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 45

Sortiert nach

Platinum resistance in breast and ovarian cancer cell lines

Journal of experimental & clinical cancer research, 2011-10, Vol.30 (1), p.91-91, Article 91

Eckstein, Niels

2011

Link zum Volltext

Verfügbarkeit prüfen

Key results of a series of surveys among German pharmacies, physicians, patients and stakeholders regarding further triptans as potential OTC products

Journal of public health, 2022-02, Vol.30 (2), p.409-415

2022

Link zum Volltext

Verfügbarkeit prüfen

To switch or not to switch—first Germany-wide study from the perspective of pharmacists in the European environment

Journal of public health, 2021-02, Vol.29 (1), p.9-17

2021

Link zum Volltext

Verfügbarkeit prüfen

Methadone-mediated sensitization of glioblastoma cells is drug and cell line dependent

Journal of cancer research and clinical oncology, 2021-03, Vol.147 (3), p.779-792

2021

Link zum Volltext

Verfügbarkeit prüfen

Thioredoxin Confers Intrinsic Resistance to Cytostatic Drugs in Human Glioma Cells

International journal of molecular sciences, 2018-09, Vol.19 (10), p.2874

2018

Link zum Volltext

Verfügbarkeit prüfen

Toxicokinetic studies of the four new psychoactive substances 4-chloroethcathinone, N-ethylnorpentylone, N-ethylhexedrone, and 4-fluoro-alpha-pyrrolidinohexiophenone

Forensic toxicology, 2020, Vol.38 (1), p.59-69

2020

Link zum Volltext

Verfügbarkeit prüfen

Hyperactivation of the Insulin-like Growth Factor Receptor I Signaling Pathway Is an Essential Event for Cisplatin Resistance of Ovarian Cancer Cells

Cancer research (Chicago, Ill.), 2009-04, Vol.69 (7), p.2996-3003

2009

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of the PI3K but not the MEK/ERK pathway sensitizes human glioma cells to alkylating drugs

Cancer cell international, 2018-05, Vol.18 (1), p.69-69, Article 69

2018

Link zum Volltext

Verfügbarkeit prüfen

Liquid Chromatography-High-Resolution Mass Spectrometry-Based In Vitro Toxicometabolomics of the Synthetic Cathinones 4-MPD and 4-MEAP in Pooled Human Liver Microsomes

Metabolites, 2020-12, Vol.11 (1), p.3

2020

Link zum Volltext

Verfügbarkeit prüfen

Clinical pharmacology of tyrosine kinase inhibitors becoming generic drugs: the regulatory perspective

Journal of experimental & clinical cancer research, 2014-02, Vol.33 (1), p.15-15, Article 15

2014

Link zum Volltext

Verfügbarkeit prüfen

Targeting adipose tissue

Diabetology and metabolic syndrome, 2012-10, Vol.4 (1), p.43-43, Article 43

2012

Link zum Volltext

Verfügbarkeit prüfen

NF546 [4,4'-(carbonylbis(imino-3,1-phenylene-carbonylimino-3,1-(4-methyl-phenylene)-carbonylimino))-bis(1,3-xylene-alpha,alpha'-diphosphonic acid) tetrasodium salt] is a non-nucleotide P2Y11 agonist and stimulates release of interleukin-8 from human monocyte-derived dendritic cells

The Journal of pharmacology and experimental therapeutics, 2010-01, Vol.332 (1), p.238

2010

Link zum Volltext

Verfügbarkeit prüfen

Epidermal Growth Factor Receptor Pathway Analysis Identifies Amphiregulin as a Key Factor for Cisplatin Resistance of Human Breast Cancer Cells

The Journal of biological chemistry, 2008-01, Vol.283 (2), p.739-750

2008

Link zum Volltext

Verfügbarkeit prüfen

Y-Box–Binding Protein YB-1 Identifies High-Risk Patients With Primary Breast Cancer Benefiting From Rapidly Cycled Tandem High-Dose Adjuvant Chemotherapy

Journal of clinical oncology, 2009-12, Vol.27 (36), p.6144-6151

2009

Link zum Volltext

Verfügbarkeit prüfen

Clinical pharmacology and regulatory consequences of GnRH analogues in prostate cancer

European journal of clinical pharmacology, 2014-07, Vol.70 (7), p.791-798

2014

Link zum Volltext

Verfügbarkeit prüfen

Allosteric modulation of muscarinic receptor signaling: alcuronium-induced conversion of pilocarpine from an agonist into an antagonist

The Journal of pharmacology and experimental therapeutics, 2002-05, Vol.301 (2), p.720

2002

Link zum Volltext

Verfügbarkeit prüfen

Analytical toxicology of the semi-synthetic cannabinoid hexahydrocannabinol studied in human samples, pooled human liver S9 fraction, rat samples and drug products using HPLC–HRMS-MS

Journal of analytical toxicology, 2023-12, Vol.47 (9), p.818-825

2023

Link zum Volltext

Verfügbarkeit prüfen

Investigations on the in vitro and in vivo metabolic fate of the new synthetic opioid desmethylmoramide using HPLC–HRMS/MS for toxicological screening purposes

Drug testing and analysis, 2024-03, Vol.16 (3), p.309-313

2024

Link zum Volltext

Verfügbarkeit prüfen

Toxicokinetics and analytical toxicology of flualprazolam: metabolic fate, isozyme mapping, human plasma concentration, and main urinary excretion products

Journal of analytical toxicology, 2020-07, Vol.44 (6), p.549-558

2020

Link zum Volltext

Verfügbarkeit prüfen

Studies on the In Vitro and In Vivo Metabolic Fate of the New Psychoactive Substance N-Ethyl-N-Propyltryptamine for Analytical Purposes

Journal of analytical toxicology, 2021-02, Vol.45 (2), p.195-202

2021

Link zum Volltext

Verfügbarkeit prüfen

The metabolic fate of two new psychoactive substances − 2‐aminoindane and N‐methyl‐2‐aminoindane − studied in vitro and in vivo to support drug testing

Drug testing and analysis, 2020-01, Vol.12 (1), p.145-151

2020

Link zum Volltext

Verfügbarkeit prüfen

Flubromazolam-Derived Designer Benzodiazepines: Toxicokinetics and Analytical Toxicology of Clobromazolam and Bromazolam

Journal of analytical toxicology, 2021-11, Vol.45 (9), p.1014-1027

2021

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological characterization of the benz[d]indolo[2,3-g]azecine LE300, a novel type of a nanomolar dopamine receptor antagonist

Naunyn-Schmiedeberg's archives of pharmacology, 2002-12, Vol.366 (6), p.543-550

2002

Link zum Volltext

Verfügbarkeit prüfen

Overcoming cisplatin resistance of ovarian cancer cells by targeted liposomes in vitro

International journal of pharmaceutics, 2010-04, Vol.389 (1), p.10-17

2010

Link zum Volltext

Verfügbarkeit prüfen

Systemic therapy of Cushing's syndrome

Orphanet journal of rare diseases, 2014-08, Vol.9 (1), p.122-122, Article 122

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(42)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(37)
Life Sciences & Biomedicine
(35)
Humans
(24)
Animals
(11)
Oncology
(11)
Cell Line, Tumor
(9)
Physical Sciences
(9)
Chemistry
(8)
Female
(8)
Chemistry, Analytical
(7)
Pharmacology & Pharmacy
(7)
Biochemistry & Molecular Biology
(6)
Biological And Medical Sciences
(6)
Medical Sciences
(6)
Medicine
(6)
Medicine & Public Health
(6)
Pharmacology. Drug Treatments
(6)
Antineoplastic Agents
(5)
Antineoplastic Agents - Pharmacology
(5)
Glioblastoma
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Platinum resistance in breast and ovarian cancer cell lines

Key results of a series of surveys among German pharmacies, physicians, patients and stakeholders regarding further triptans as potential OTC products

To switch or not to switch—first Germany-wide study from the perspective of pharmacists in the European environment

Methadone-mediated sensitization of glioblastoma cells is drug and cell line dependent

Thioredoxin Confers Intrinsic Resistance to Cytostatic Drugs in Human Glioma Cells

Toxicokinetic studies of the four new psychoactive substances 4-chloroethcathinone, N-ethylnorpentylone, N-ethylhexedrone, and 4-fluoro-alpha-pyrrolidinohexiophenone

Hyperactivation of the Insulin-like Growth Factor Receptor I Signaling Pathway Is an Essential Event for Cisplatin Resistance of Ovarian Cancer Cells

Inhibition of the PI3K but not the MEK/ERK pathway sensitizes human glioma cells to alkylating drugs

Liquid Chromatography-High-Resolution Mass Spectrometry-Based In Vitro Toxicometabolomics of the Synthetic Cathinones 4-MPD and 4-MEAP in Pooled Human Liver Microsomes

Clinical pharmacology of tyrosine kinase inhibitors becoming generic drugs: the regulatory perspective

Targeting adipose tissue

NF546 [4,4'-(carbonylbis(imino-3,1-phenylene-carbonylimino-3,1-(4-methyl-phenylene)-carbonylimino))-bis(1,3-xylene-alpha,alpha'-diphosphonic acid) tetrasodium salt] is a non-nucleotide P2Y11 agonist and stimulates release of interleukin-8 from human monocyte-derived dendritic cells

Epidermal Growth Factor Receptor Pathway Analysis Identifies Amphiregulin as a Key Factor for Cisplatin Resistance of Human Breast Cancer Cells

Y-Box–Binding Protein YB-1 Identifies High-Risk Patients With Primary Breast Cancer Benefiting From Rapidly Cycled Tandem High-Dose Adjuvant Chemotherapy

Clinical pharmacology and regulatory consequences of GnRH analogues in prostate cancer

Allosteric modulation of muscarinic receptor signaling: alcuronium-induced conversion of pilocarpine from an agonist into an antagonist

Analytical toxicology of the semi-synthetic cannabinoid hexahydrocannabinol studied in human samples, pooled human liver S9 fraction, rat samples and drug products using HPLC–HRMS-MS

Investigations on the in vitro and in vivo metabolic fate of the new synthetic opioid desmethylmoramide using HPLC–HRMS/MS for toxicological screening purposes

Toxicokinetics and analytical toxicology of flualprazolam: metabolic fate, isozyme mapping, human plasma concentration, and main urinary excretion products

Studies on the In Vitro and In Vivo Metabolic Fate of the New Psychoactive Substance N-Ethyl-N-Propyltryptamine for Analytical Purposes

The metabolic fate of two new psychoactive substances − 2‐aminoindane and N‐methyl‐2‐aminoindane − studied in vitro and in vivo to support drug testing

Flubromazolam-Derived Designer Benzodiazepines: Toxicokinetics and Analytical Toxicology of Clobromazolam and Bromazolam

Pharmacological characterization of the benz[d]indolo[2,3-g]azecine LE300, a novel type of a nanomolar dopamine receptor antagonist

Overcoming cisplatin resistance of ovarian cancer cells by targeted liposomes in vitro

Systemic therapy of Cushing's syndrome

Suchergebnisse filtern